Biotechnology Assets, S.A. (BME: BST)
Spain
· Delayed Price · Currency is EUR 0.303
+0.008 (2.54%)
Dec 18, 2024, 5:21 PM CET
Biotechnology Assets Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -3.05 | 1.57 | -1.94 | -3.01 | -8.61 | -10.08 | Upgrade
|
| Depreciation & Amortization | 0.23 | 1.01 | 1.03 | 1.03 | 1.04 | 2.07 | Upgrade
|
| Other Amortization | 2.09 | 1.45 | 1.12 | 1 | 1.17 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.05 | 0.05 | - | 0.06 | 1.66 | 0.16 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | - | 0.26 | Upgrade
|
| Other Operating Activities | 0.78 | -3.57 | -0.07 | -0.08 | 8.16 | 7.72 | Upgrade
|
| Change in Accounts Receivable | 0.13 | -1.02 | 0.37 | 0.06 | 13.12 | -7.26 | Upgrade
|
| Change in Inventory | - | - | - | 0.02 | 8.01 | -1.47 | Upgrade
|
| Change in Accounts Payable | 0.28 | 0.06 | -0.52 | -0.76 | -10.26 | - | Upgrade
|
| Change in Other Net Operating Assets | 0.47 | 0.47 | - | 0.18 | 1.41 | -1.12 | Upgrade
|
| Operating Cash Flow | 0.99 | 0.05 | -0.02 | -1.5 | 8.81 | -16.8 | Upgrade
|
| Capital Expenditures | -0.07 | -0.07 | -0.13 | -0.02 | -0 | -6.07 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 44.84 | 39.44 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.51 | -0.26 | -1.99 | -0.64 | -0.39 | -1.41 | Upgrade
|
| Investment in Securities | - | - | - | - | 0.39 | - | Upgrade
|
| Other Investing Activities | 0.33 | - | - | - | - | -39.44 | Upgrade
|
| Investing Cash Flow | -0.25 | -0.33 | -2.12 | -0.66 | 44.84 | -7.48 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 0.07 | - | 25.65 | Upgrade
|
| Long-Term Debt Issued | - | 0.59 | 0.59 | 0.73 | - | 30.45 | Upgrade
|
| Total Debt Issued | 1.12 | 0.59 | 0.59 | 0.8 | - | 56.1 | Upgrade
|
| Short-Term Debt Repaid | - | -0.13 | -0.22 | - | -43.36 | -1.36 | Upgrade
|
| Long-Term Debt Repaid | - | -0.59 | -0.59 | -0.56 | -14.56 | -31.59 | Upgrade
|
| Total Debt Repaid | -1.45 | -0.72 | -0.81 | -0.56 | -57.93 | -32.95 | Upgrade
|
| Net Debt Issued (Repaid) | -0.33 | -0.13 | -0.22 | 0.24 | -57.93 | 23.14 | Upgrade
|
| Issuance of Common Stock | 0.51 | 0.51 | 1.51 | 3.01 | - | - | Upgrade
|
| Repurchase of Common Stock | -0.18 | -0.08 | -0.08 | -0.01 | - | - | Upgrade
|
| Other Financing Activities | -0.43 | -0.37 | -0.06 | 0.05 | 0.07 | 0.35 | Upgrade
|
| Financing Cash Flow | -0.43 | -0.06 | 1.15 | 3.28 | -57.86 | 23.5 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.03 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 1.64 | Upgrade
|
| Net Cash Flow | 0.31 | -0.34 | -0.99 | 1.12 | -4.21 | 0.82 | Upgrade
|
| Free Cash Flow | 0.92 | -0.02 | -0.14 | -1.52 | 8.8 | -22.87 | Upgrade
|
| Free Cash Flow Margin | 27.39% | -0.56% | -4.90% | -46.29% | 304.47% | -706.54% | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.00 | -0.00 | -0.03 | 0.22 | -0.58 | Upgrade
|
| Cash Interest Paid | 0.12 | 0.07 | 0.13 | 0.53 | 0.18 | 2.24 | Upgrade
|
| Cash Income Tax Paid | - | - | 0.02 | 0.11 | 0.02 | - | Upgrade
|
| Levered Free Cash Flow | 0.83 | 2.5 | -0.97 | -1.77 | 9.87 | -15.81 | Upgrade
|
| Unlevered Free Cash Flow | 1 | 2.69 | -0.76 | -1.24 | 10.08 | -15.58 | Upgrade
|
| Change in Net Working Capital | -0.48 | 1.14 | -0.29 | 1.31 | -9.01 | 8.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.